ACI's 2nd Annual Forum on Paragraph IV Disputes
ACI's 2nd Annual Forum on Paragraph IV DisputesDecember 6 - 7, 2011Hotel Nikko, San Francisco, CA
Widely recognized for setting the standards for Paragraph IV litigation, this conference offers a platform to share insights into the latest challenges in the increasingly high-stakes and complicated area of Hatch-Waxman litigation. At _ACI_s 2nd Annual West Coast edition of its acclaimed Paragraph IV Disputes conference, an experienced faculty of renowned litigators and judges will guide you through every stage of a Paragraph IV challenge to help you formulate the offensive moves and defensive plays for the next round in the no-holds barred fight for pharmaceutical product market share. Additionally, in the wake of major developments in pay-for-delay, learn what the FTC deems foul and fair in the settlement of Paragraph IV disputes in order to draft and structure a settlement that will receive FTC approval.
With hundreds of billions of dollars at stake as blockbuster drugs go off patent in 2014, Hatch-Waxman litigation will only intensify as branded companies fight to delay generic entry and extend patent life through all means possible, and as generic companies fight amongst themselves for fewer opportunities to attain the prized 180-day exclusivity period. Constantly evolving case law and legislative developments including long-awaited patent reform create more questions and will spawn more litigation as well. At this in-depth strategy session on the nuances of PIV litigation, our West Coast delegates will gain the tools to advance a novel claim or defense to protect patents and market share based on the expertise of trial leading patent counsel from generic and branded companies- and the judges- who have experienced the intricacies of Hatch Waxman litigation first hand. Featuring an up-to-the-minute analysis of the latest game-changing case law developments regarding inequitable conduct, inducement of infringement and the standard of invalidity, this conference will give our attendees the tools and litigation strategies to help both brand name and generic companies protect market share and ultimately profits.
Paul Hastings partner Joe O'Malley is a featured speaker on December 6th. For more information and to register, visit the